PSI-7977

DRUG2 trials

Sponsors

Bristol-Myers Squibb, Gilead Sciences

Conditions

Chronic Hepatitis CHepatitis C

Phase 1

Open-Label Hepatic Impairment Study

CompletedNCT01497327

Gilead SciencesHepatitis C

Start: 2011-07-31End: 2012-01-31Updated: 2012-06-08

Phase 2

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

CompletedNCT01359644

Bristol-Myers SquibbChronic Hepatitis C

Start: 2011-06-30End: 2013-10-31Updated: 2015-10-23

Related Papers

Safety and efficacy of sofosbuvir-based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta-analysis.

2022-06-083 citations

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

New England Journal of Medicine2014-01-151190 citations